|
|
||||||||
The Journal of Immunology, Vol 159, Issue 9 4307-4315, Copyright © 1997 by American Association of Immunologists
ARTICLES |
M Simarro, C Pelassy, J Calvo, L Places, C Aussel and F Lozano
Servei d'Immunologia, Hospital Clinic, Barcelona, Spain.
CD5 is a 67-kDa surface glycoprotein found in association with the Ag receptor complex on both T and B lymphocytes. CD5 modulates Ag receptor- mediated immune responses, but the molecular mechanisms of its action remain unclear. In this respect, the assessment of the relative and unique contribution of CD5 in cell signaling events is a crucial point. We have used Jurkat variants and anti-CD5 mAbs to show that the CD5 signaling pathway is distinct from that used by the TCR/CD3 complex. We hereby identify two independent mechanisms of CD5-mediated diacylglycerol release by virtue of their different kinetics: 1) an early and transient diacylglycerol increase that results from the activation of a phosphatidylcholine-specific phospholipase C, and 2) a late and sustained increase that requires de novo phospholipid synthesis. Studies performed on a TCR/CD3-deficient Jurkat cell variant indicate that only the CD5-mediated phosphatidylcholine-specific phospholipase C activation is dependent on TCR/CD3 expression. Mutational analyses of CD5 demonstrate that both mechanisms are dependent on the integrity of the CD5 distal cytoplasmic region. Our results show that CD5 is a signaling molecule per se that uses mechanisms resembling those used by some cytokine receptors (such as IL- 1 or TNF receptors) to modulate lymphocyte activation.
This article has been cited by other articles:
![]() |
M.-R. Sarrias, M. Farnos, R. Mota, F. Sanchez-Barbero, A. Ibanez, I. Gimferrer, J. Vera, R. Fenutria, C. Casals, J. Yelamos, et al. CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock PNAS, July 10, 2007; 104(28): 11724 - 11729. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ibanez, M.-R. Sarrias, M. Farnos, I. Gimferrer, C. Serra-Pages, J. Vives, and F. Lozano Mitogen-Activated Protein Kinase Pathway Activation by the CD6 Lymphocyte Surface Receptor J. Immunol., July 15, 2006; 177(2): 1152 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sandra, M. Degli Esposti, K. Ndebele, P. Gona, D. Knight, M. Rosenquist, and R. Khosravi-Far Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alters Mitochondrial Membrane Lipids Cancer Res., September 15, 2005; 65(18): 8286 - 8297. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gimferrer, A. Ibanez, M. Farnos, M.-R. Sarrias, R. Fenutria, S. Rosello, P. Zimmermann, G. David, J. Vives, C. Serra-Pages, et al. The Lymphocyte Receptor CD6 Interacts with Syntenin-1, a Scaffolding Protein Containing PDZ Domains J. Immunol., August 1, 2005; 175(3): 1406 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gimferrer, M. Calvo, M. Mittelbrunn, M. Farnos, M. R. Sarrias, C. Enrich, J. Vives, F. Sanchez-Madrid, and F. Lozano Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation J. Immunol., August 15, 2004; 173(4): 2262 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arman, J. Calvo, M. E. Trojanowska, P. N. Cockerill, M. Santana, M. Lopez-Cabrera, J. Vives, and F. Lozano Transcriptional Regulation of Human CD5: Important Role of Ets Transcription Factors in CD5 Expression in T Cells J. Immunol., June 15, 2004; 172(12): 7519 - 7529. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gimferrer, M. Farnos, M. Calvo, M. Mittelbrunn, C. Enrich, F. Sanchez-Madrid, J. Vives, and F. Lozano The Accessory Molecules CD5 and CD6 Associate on the Membrane of Lymphoid T Cells J. Biol. Chem., February 28, 2003; 278(10): 8564 - 8571. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Azzam, J. B. DeJarnette, K. Huang, R. Emmons, C.-S. Park, C. L. Sommers, D. El-Khoury, E. W. Shores, and P. E. Love Fine Tuning of TCR Signaling by CD5 J. Immunol., May 1, 2001; 166(9): 5464 - 5472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Vila, J. Calvo, L. Places, O. Padilla, M. Arman, I. Gimferrer, C. Aussel, J. Vives, and F. Lozano Role of Two Conserved Cytoplasmic Threonine Residues (T410 and T412) in CD5 Signaling J. Immunol., January 1, 2001; 166(1): 396 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gary-Gouy, P. Bruhns, C. Schmitt, A. Dalloul, M. Daeron, and G. Bismuth The Pseudo-immunoreceptor Tyrosine-based Activation Motif of CD5 Mediates Its Inhibitory Action on B-cell Receptor Signaling J. Biol. Chem., January 7, 2000; 275(1): 548 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Simarro, J. Calvo, J. M. Vila, L. Places, O. Padilla, J. Alberola-Ila, J. Vives, and F. Lozano Signaling Through CD5 Involves Acidic Sphingomyelinase, Protein Kinase C-{zeta}, Mitogen-Activated Protein Kinase Kinase, and c-Jun NH2-Terminal Kinase J. Immunol., May 1, 1999; 162(9): 5149 - 5155. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Raman and R. P. Kimberly Cutting Edge: Differential CD5-Dependent Regulation of CD5-Associated CK2 Activity in Mature and Immature T Cells: Implication on TCR/CD3-Mediated Activation J. Immunol., December 1, 1998; 161(11): 5817 - 5820. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Calvo, J. M. Vilda, L. Places, M. Simarro, O. Padilla, D. Andreu, K. S. Campbell, C. Aussel, and F. Lozano Human CD5 Signaling and Constitutive Phosphorylation of C-Terminal Serine Residues by Casein Kinase II J. Immunol., December 1, 1998; 161(11): 6022 - 6029. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Raman, A. Kuo, J. Deshane, D. W. Litchfield, and R. P. Kimberly Regulation of Casein Kinase 2 by Direct Interaction with Cell Surface Receptor CD5 J. Biol. Chem., July 24, 1998; 273(30): 19183 - 19189. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |